Pfizer P/B Ratio
Pfizer (PFIZER) P/B ratio is 5.06 (High), book value per share ₹913.70 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. View PFIZER 52-week high low for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
PFIZER P/B Ratio — Valuation Insights & Book Value Analysis
Pfizer price-to-book ratio interpretation, valuation status and historical context — current P/B 5.06 (High). For live price, earnings yield and the full fundamental profile, see Pfizer screener.
- Stock appears overvalued with PB of 5.06, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.33
Pfizer P/B Ratio Historical Trend
PFIZER annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with PFIZER fair price to assess whether the stock is under or overvalued.
PFIZER Historical P/B Ratio — Book Value Per Share & Year-End Price
Pfizer annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 5.06 | ₹913.7 | ₹4622.60 | ₹4,203 | High |
| 2025 | 5.44 | ₹916.74 | ₹4987.70 | ₹4,217 | High |
| 2024 | 6.76 | ₹781.74 | ₹5281.50 | ₹3,596 | High |
| 2023 | 6.12 | ₹697.17 | ₹4268.95 | ₹3,207 | High |
| 2022 | 7.12 | ₹622.61 | ₹4431.70 | ₹2,864 | High |
PFIZER vs Healthcare Peers — P/B Ratio Comparison
Pfizer P/B 5.06 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |